Fate Therapeutics, Inc. (FATE)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.60-0.17 (-6.14%)
At close: 4:00 PM EDT
People also watch:
BINDEVOKCNATHTBXGNCA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.75
Prev Close2.77
Bid2.50 x 10000
Ask3.99 x 1400
Day's Range2.50 - 2.76
52wk Range1.46 - 7.29
1y Target EstN/A
Market Cap75.13M
P/E Ratio (ttm)-2.41
BetaN/A
Volume300,616
Avg Vol (3m)359,803
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube13 days ago

    ETF’s with exposure to Fate Therapeutics, Inc. : August 12, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Fate Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to FATE-US. Comparing the performance and risk of Fate Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Fate Therapeutics, Inc. :FATE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
    Capital Cube15 days ago

    Fate Therapeutics, Inc. :FATE-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016

    Categories: Yahoo Finance Click here to see latest analysis Fate Therapeutics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Fate Therapeutics, Inc. – Sarepta Therapeutics, Inc., Becton, Dickinson and Company, PTC Therapeutics, Inc., Neurocrine Biosciences, Inc. and Ionis Pharmaceuticals, Inc. (SRPT-US, BDX-US, PTCT-US, NBIX-US and ... Read more (Read more...)

  • GlobeNewswire15 days ago

    Fate Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference

    SAN DIEGO, Aug. 10, 2016-- Fate Therapeutics, Inc., a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that ...